Why I hold BEAM therapeutics stock and my position plans in future

🎦 summary ⌲ Not all CRISPR based gene editing companies are the same!!! As of Feb 2020, there are 2 generations where BEAM therapeutics engineered CRISPR-Cas is considered newer. Their version is superior to generation 1 CRISPR-Cas in several ways and this video seeks to explain how and why they are superior so that biotech stock pickers can be informed! I also make predictions about where this technology will go in the future, tune in to 🧐

⏰
00:00 Context of video
00:37 Reasons why BEAM therapeutics is superior gene editing method
05:36 I detail my plans for my BEAM stock holdings
06:31 Where I think gene editing can go in the future, increasing company growth

Subscribe ⌲ https://www.youtube.com/c/BenjaminYangCW?sub_confirmation=1
🖥 ⌲ https://byang.info
Disclosure ⌲ BYang is long (and own) BEAM stock

Видео Why I hold BEAM therapeutics stock and my position plans in future канала Benjamin Yang